J&J vaccine to remain in limbo while U.S. health officials seek more data on rare blood clots
WASHINGTON, DC — Johnson & Johnson’s Covid-19 vaccine will remain in limbo a while longer. That word comes after U.S. health advisers told…
Continue Reading